Neuberger Berman Group
VIRX

Neuberger Berman Group’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Neuberger Berman Group’s Portfolio VIRX Stock Details VIRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-140,555
Closed -$576K – 1649
2017
Q1 		$576K Buy
140,555
+20,000
+17% +$82K ﹤0.01% 1266
2016
Q4 		$436K Buy
+120,555
New +$436K ﹤0.01% 1311